Expanding VET-lirn AMR surveillance capacity through hybrid long-read sequencing at the oregon veterinary diagnostic laboratory

Active Cooperative Agreement Awarded

Award ID
U18FD008942
Recipient
Awarding agency
Obligated
$60,000

Award facts

Assistance listing
93.103 Food and Drug Administration Research
Completion date 18% complete
Funding agency
Food and Drug Administration Department of Health and Human Services
Place of performance
Corvallis, OR 97331, USA

Award details come from USAspending.gov.

Description

Abstract
Resistance to existing antimicrobials is a primary public health concern globally. Mobile genetic elements, including plasmids and transposons, provide an important route to acquire genes that confer antimicrobial resistance (AMR). Animals are important potential sources of AMR- containing bacteria, and veterinary diagnostic laboratories are at the critical interface between animals and humans. The oregon veterinary diagnostic laboratory at oregon state university (OVDL) has been a VET-lirn member laboratory providing diagnostic services to a regionally diverse animal population including companion animals, equines, food animals, camelids, and wildlife across the pacific northwest. Current surveillance efforts rely on bacterial whole genome sequencing to support AMR surveillance; however, short-read sequencing alone is often inadequate to capture detailed structural genome information and repetitive elements. We propose a hybrid sequencing approach using long-read sequencing generated by the oxford nanopore minion MK1C, supplemented by short-read sequencing using the illumina miseq I100 instrument. This approach will efficiently provide complete bacterial genome assemblies, including mobile genetic elements. This project will generate genomes from a total of 650 isolates encompassing a range of bacterial species and animal hosts, combined with phenotypic antimicrobial susceptibility data. This dataset will provide the first regional baseline of mobile AMR element prevalence in veterinary diagnostic isolates, linked to phenotypic susceptibility data, and will be deposited to the VET-lirn ncbi bioproject for network-wide access.

Quick answers

Who received award U18FD008942?

U18FD008942 was awarded to Oregon State University by FDA Office of Acquisition and Grant Services (Food and Drug Administration) on September 23, 2026.

How much is award U18FD008942 worth?

$60,000 has been obligated on U18FD008942.

Which agency awarded U18FD008942?

FDA Office of Acquisition and Grant Services (Food and Drug Administration) awarded U18FD008942, with funding from Food and Drug Administration (Department of Health and Human Services).

On GovTribe

See this award's full record

  • Every transaction and subaward
  • The recipient's other awards and teaming partners
  • Similar grant awards
  • Ask GovTribe AI about this award